The IFN-λ receptor (IFNLR) is mainly expressed at epithelial barriers, and IFN-λ responses are therefore often characterized by their ability to confer localized antiviral protection at the site of infection without driving damaging proinflammatory responses like those associated with IFN-α/β. The gene discussed is IFNLR1; the disease is infection.